A study supported by the North Carolina Translational and Clinical Sciences (NC TraCS) Institute has developed a "smart" insulin to reduce complications in people who use insulin to manage diabetes. The research was led by former University of North Carolina at Chapel Hill researcher Dr. Zhen Gu more
Dr. John B. Buse, Director of the North Carolina Translational and Clinical Sciences Institute (NC TraCS) at UNC-Chapel Hill, is the recipient of the 2019 Outstanding Achievement in Clinical Diabetes Research Award from the American Diabetes Association.
Dr. Buse’s breadth of more
More 30 million Americans have Type 2 Diabetes related to the obesity epidemic—this is approximately 9.4 percent of the entire U.S. population. Physicians and researchers know that lifestyle interventions can prevent diabetes, slow its progression and decrease the need for medications. more